Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction. (15th May 2023)
- Record Type:
- Journal Article
- Title:
- Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction. (15th May 2023)
- Main Title:
- Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction
- Authors:
- Yu, Zhe
Kisner, Alexandre
Bhatt, Amy
Polter, Abigail M.
Marvar, Paul J. - Abstract:
- Abstract: The renin-angiotensin system (RAS) has been linked to the pathophysiology of posttraumatic stress disorder (PTSD) however, the underlying neurobiological mechanism(s) remain elusive. Here we utilized angiotensin II receptor type 1 (AT1 R) transgenic mice combined with neuroanatomical, behavioral, and electrophysiological approaches, to examine the role of the central amygdala (CeA) expressing AT1 R neurons in fear and anxiety-related behavior. Within the major amygdala subdivisions, AT1 R + neurons were localized to gamma-aminobutyric acid (GABA) expressing neurons in the lateral division of the central amygdala (CeL), and the majority of them were identified as protein kinase C-δ positive (PKCδ + ) neurons. Following CeA-AT1 R deletion using cre-expressing lentiviral delivery in AT1 R-Flox mice, generalized anxiety and locomotor activity as well as the acquisition of conditioned fear were unaltered while the acquisition of extinction learning, as measured by percent freezing behavior, was significantly enhanced. During electrophysiological recordings of CeL-AT1 R + neurons, the application of angiotensin II (1 μm) increased the amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs) and decreased the excitability of CeL-AT1 R + neurons. Overall, these findings demonstrate that CeL-AT1 R-expressing neurons play a role in fear extinction, potentially through facilitated CeL-AT1 R + GABAergic inhibition. These results provide new evidence for mechanisms ofAbstract: The renin-angiotensin system (RAS) has been linked to the pathophysiology of posttraumatic stress disorder (PTSD) however, the underlying neurobiological mechanism(s) remain elusive. Here we utilized angiotensin II receptor type 1 (AT1 R) transgenic mice combined with neuroanatomical, behavioral, and electrophysiological approaches, to examine the role of the central amygdala (CeA) expressing AT1 R neurons in fear and anxiety-related behavior. Within the major amygdala subdivisions, AT1 R + neurons were localized to gamma-aminobutyric acid (GABA) expressing neurons in the lateral division of the central amygdala (CeL), and the majority of them were identified as protein kinase C-δ positive (PKCδ + ) neurons. Following CeA-AT1 R deletion using cre-expressing lentiviral delivery in AT1 R-Flox mice, generalized anxiety and locomotor activity as well as the acquisition of conditioned fear were unaltered while the acquisition of extinction learning, as measured by percent freezing behavior, was significantly enhanced. During electrophysiological recordings of CeL-AT1 R + neurons, the application of angiotensin II (1 μm) increased the amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs) and decreased the excitability of CeL-AT1 R + neurons. Overall, these findings demonstrate that CeL-AT1 R-expressing neurons play a role in fear extinction, potentially through facilitated CeL-AT1 R + GABAergic inhibition. These results provide new evidence for mechanisms of angiotensinergic neuromodulation of the CeL and its role in fear extinction and may aid in further advancing targeted novel therapies for improving maladaptive fear learning processes associated with PTSD. Highlights: Agtr1a is uniquely expressed in mouse CeL compared to other amygdala subnuclei. CeL- Agtr1a contributes to the quicker acquisition of extinction learning. CeL-Agtr1a positive neurons predominately co-localize with previously identified PKCδ+ CeLoff neurons. AT1R activation with angiotensin II increases GABAergic inhibition in CeL-Agtr1a + neurons. … (more)
- Is Part Of:
- Neuropharmacology. Volume 229(2023)
- Journal:
- Neuropharmacology
- Issue:
- Volume 229(2023)
- Issue Display:
- Volume 229, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 229
- Issue:
- 2023
- Issue Sort Value:
- 2023-0229-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-05-15
- Subjects:
- Angiotensin II -- PTSD -- Pavlovian fear conditioning -- AT1R -- Amygdala
Neuropsychopharmacology -- Periodicals
Autonomic Agents -- Periodicals
Neuropsychopharmacologie -- Périodiques
Neuropsychopharmacology
Periodicals
Electronic journals
615.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00283908 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuropharm.2023.109460 ↗
- Languages:
- English
- ISSNs:
- 0028-3908
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.517500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26453.xml